Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Quincy Gibbs

Dentist, Prosthodontics Walnut Creek, CA Doctor of Dentistry

NPI 1063626166 CMS profile 707308

1111 Civic Dr, #320, Walnut Creek, CA 94596

Open in the dashboard

General payments

$63,275

150 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Quincy Gibbs of Walnut Creek, CA is reported in the CMS Open Payments database as having received $63,275 across 150 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Dentist, Prosthodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $624 15
2024 General $9,002 25
2023 General $27,453 36
2022 General $20,193 27
2021 General $2,589 11
2020 General $2,138 15
2019 General $1,277 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Quincy Gibbs
  • Dentist, Prosthodontics median
  • Middle half of Dentist, Prosthodontics
  • National median

In program year 2025, general payments to Quincy Gibbs were reported at $624. Among 1,396 Dentist, Prosthodontics profiles paid that year, the median was $118 and the middle half received between $44 and $351.

Show as a table
Year Quincy Gibbs Dentist, Prosthodontics median Middle half National median
2019 $1,277 $107 $36–$389 $163
2020 $2,138 $100 $41–$311 $114
2021 $2,589 $129 $40–$398 $132
2022 $20,193 $129 $47–$460 $149
2023 $27,453 $135 $44–$432 $160
2024 $9,002 $142 $45–$420 $164
2025 $624 $118 $44–$351 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $56,129 123 payments
  2. Keystone Dental Inc. $6,702 12 payments
  3. Implant Direct Sybron International LLC $165 3 payments
  4. Nobel Biocare USA $117 6 payments
  5. BioHorizons Implant Systems Inc. $97 2 payments
  6. Dentsply Sirona Inc $65 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $38,475 18 payments
  2. Travel and Lodging $12,056 15 payments
  3. Education $5,144 7 payments
  4. Food and Beverage $2,409 93 payments
  5. Gift $2,263 4 payments
  6. Entertainment $2,158 11 payments
  7. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  8. Consulting Fee $270 1 payment
Products named General payments · program years 2019–2025
  1. NOBELPARALLEL $117 6 payments
  2. NOBELACTIVE Dental implant $117 6 payments
  3. BIOHORIZONS Implant Dentistry $97 2 payments
  4. BIOHORIZONS Implant Dentistry $97 2 payments
  5. BIOHORIZONS Implant Dentistry $97 2 payments
  6. BIOHORIZONS Implant Dentistry $97 2 payments
  7. BIOHORIZONS Implant Dentistry $97 2 payments
  8. SIMPLYFIXED INTERACTIVE $88 1 payment
  9. NOBELACTIVE Dental implant $38 1 payment
  10. ASTRA TECH Implant System $33 2 payments
  11. Other $112 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

100

Median for Dentist: 47

Drug cost

$687

Median for Dentist: $159

Branded share of claims

0%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 57 $484
Amoxicillin Generic 43 $203

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

150 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Prosthodontics in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record